Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
JNMA J Nepal Med Assoc ; 62(269): 55-57, 2024 Jan 02.
Article in English | MEDLINE | ID: mdl-38410004

ABSTRACT

Congenital pulmonary airway malformation is a rare congenital abnormality of the lungs. It can manifest at any age and can lead to significant morbidity and mortality in infants and children. Some individuals with congenital lung malformations may present with respiratory symptoms right after birth, while others may remain asymptomatic for extended periods. We present a case of a 4-year-old female child who experienced recurrent chest infections. Imaging revealed type I congenital pulmonary airway malformation with an underlying infection. Despite the increased risks associated with surgery and the complexity of the disease, the patient underwent a posterolateral thoracotomy with resection of the right lower lobe. The patient achieved successful outcomes and was able to recover successfully following the surgery. This case study holds significance because several studies have focused on the timing and outcomes of surgical intervention in asymptomatic cases, there remains a lack of consensus regarding symptomatic patients and their outcomes after surgery. Keywords: case reports; neonates; pneumonia.


Subject(s)
Cystic Adenomatoid Malformation of Lung, Congenital , Lung Neoplasms , Pneumonia , Infant , Infant, Newborn , Child , Female , Humans , Child, Preschool , Lung/diagnostic imaging , Lung/surgery , Cystic Adenomatoid Malformation of Lung, Congenital/diagnosis , Cystic Adenomatoid Malformation of Lung, Congenital/diagnostic imaging , Pneumonia/complications
2.
Sci Rep ; 10(1): 10850, 2020 07 02.
Article in English | MEDLINE | ID: mdl-32616741

ABSTRACT

Isobutanol, in spite of its significant superiority over ethanol as a biofuel, remains commercially non-viable due to the non-availability of a suitable chassis which can handle the solvent toxicity associated with its production. To meet this challenge, we chose Lactococcus lactis which is known for its ability to handle environmental stress and carried out Adaptive laboratory evolution (ALE) in a continuous stirred tank reactor (CSTR) to evolve an isobutanol tolerant strain. The strain was grown for more than 60 days (> 250 generations) while gradually increasing the selection pressure, i.e. isobutanol concentration, in the feed. This led to the evolution of a strain that had an exceptionally high tolerance of up to 40 g/l of isobutanol even though a scanning electron microscope (SEM) study as well as analysis of membrane potential revealed only minor changes in cellular morphology. Whole genome sequencing which was done to confirm the strain integrity also showed comparatively few mutations in the evolved strain. However, the criticality of these mutations was reflected in major changes that occurred in the transcriptome, where gene expression levels from a wide range of categories that involved membrane transport, amino acid metabolism, sugar uptake and cell wall synthesis were significantly altered. Analysing the synergistic effect of these changes that lead to the complex phenotype of isobutanol tolerance can help in the construction of better host platforms for isobutanol production.


Subject(s)
Bacterial Proteins/metabolism , Butanols/pharmacology , Drug Tolerance/genetics , Genomics/methods , Laboratories/statistics & numerical data , Lactococcus lactis/genetics , Transcriptome/drug effects , Bacterial Proteins/genetics , Lactococcus lactis/drug effects , Lactococcus lactis/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...